• Terms and Conditions
  • Privacy Policy
  • DMCA
  • Disclaimer
  • Cookie Privacy Policy
  • Contact Us
Sixsense News
Advertisement
  • Home
  • Business
  • Economy
  • Fintech
  • Finance
  • Insurance
  • Market
  • Startups
No Result
View All Result
  • Home
  • Business
  • Economy
  • Fintech
  • Finance
  • Insurance
  • Market
  • Startups
No Result
View All Result
Sixsense News
No Result
View All Result
Home Business

WHO issues alert against 4 cough syrups made by India’s Maiden Pharmaceuticals

Freddie Green by Freddie Green
October 5, 2022
in Business
0


The World Health Organization on Wednesday issued an alert against four cough and cold syrups made by India-based Maiden Pharmaceuticals, saying that it might be linked to the deaths of 66 minor children in the Gambia. The international health body reportedly said that the cough and cold syrups have ingredients, such as diethylene glycol and ethylene glycol, which can be toxic for human beings.  

The global body said it is conducting further investigation with the company and Indian regulatory authorities.

As per reports, last month the Gambian government reported that it has been investigating the deaths of small children under the age of 5 years as there was a spike in cases of acute kidney injury, which surfaced in July.

The four syrups that have been identified are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup, as per news reports.

“Laboratory analysis of samples (in the syrup) of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants,” the WHO said in a medical product alert.

In a tweet, Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, said: “WHO has today issued a medical product alert for four contaminated medicines identified in The Gambia that have been potentially linked with acute kidney injuries and 66 deaths among children.”

He added that the loss of these young lives is beyond heartbreaking for their families. The four medicines are cough and cold syrups produced by Maiden Pharmaceuticals Limited, in India.

“The four medicines are cough and cold syrups produced by Maiden Pharmaceuticals Limited, in India. WHO is conducting further investigation with the company and regulatory authorities in India”-@DrTedros https://t.co/PceTWc836t

— World Health Organization (WHO) (@WHO) October 5, 2022

As per reports, Ghebreyesus said at a press conference on Wednesday: “While the contaminated products have so far only been detected in the Gambia, they may have been distributed to other countries.”

He added that the global health body will ask all countries to detect and remove these products from circulation to prevent further harm to patients.

(With agency inputs)





Source link

Related articles

Navigator Holdings Ltd. (NVGS) Q4 2022 Earnings Call Transcript

March 21, 2023

GameStop shares surge as videogame retailer posts surprise profit By Reuters

March 21, 2023
Tags: alertcoughIndiasissuesMaidenPharmaceuticalssyrups

Related Posts

Navigator Holdings Ltd. (NVGS) Q4 2022 Earnings Call Transcript

by Freddie Green
March 21, 2023
0

Navigator Holdings Ltd. (NYSE:NVGS) Q4 2022 Earnings Conference Call March 21, 2023 10:00 AM ET Company Participants Randy Giveans -...

GameStop shares surge as videogame retailer posts surprise profit By Reuters

by Reuters
March 21, 2023
0

© Reuters. FILE PHOTO: A screen displays the logo and trading information for GameStop on the floor of the New...

Smotrich dismisses dire warnings by top Treasury officials

by Oren Dori
March 21, 2023
0

Opposition to the government's judicial overhaul has reached boiling point in the Ministry of Finance. Last night, Minister of...

Amazon, Target pick up Bed Bath & Beyond’s lost market share – BofA (NASDAQ:BBBY)

by Freddie Green
March 21, 2023
0

Joe Raedle/Getty Images News According to a survey results published by Bank of America on Tuesday, retail leaders are consolidating...

Toro Company Declares $0.34 Quarterly Dividend; 1.2% Yield By Investing.com

by Investing.com
March 21, 2023
0

Toro Company (TTC) Declares $0.34 Quarterly Dividend; 1.2% Yield Toro Company (TTC) declared a quarterly dividend of $0.34 per share,...

Load More

Navigator Holdings Ltd. (NVGS) Q4 2022 Earnings Call Transcript

March 21, 2023

GameStop shares surge as videogame retailer posts surprise profit By Reuters

March 21, 2023

Mineral miner NioCorp shares fall 8% in wake of uplisting, SPAC merger (NIOBF)

March 21, 2023

Earnings Infographic: Highlights of Nike’s Q3 2023 results

March 21, 2023

The Benefits of Massage for People with Multiple Sclerosis

March 21, 2023

Smotrich dismisses dire warnings by top Treasury officials

March 21, 2023
Sixsense News

© 2022 Sixsense News All Rights Reserved.

Navigate Site

  • Terms and Conditions
  • Privacy Policy
  • DMCA
  • Disclaimer
  • Cookie Privacy Policy
  • Contact Us

Follow Us

No Result
View All Result
  • #3158 (no title)
  • Business
  • Economy
  • Finance
  • Fintech
  • Insurance
  • Market
  • Startups

© 2022 Sixsense News All Rights Reserved.